LH

NYSE

LABCORP HOLDINGS INC.

Health Care, Health Care Services

$319.17

close 7 Aug 2026

+19.24%

52-week change

$25.82B

market cap

$244.52

$319.94

52-week range

Valuation

Market cap$25.82B

P/E (TTM / 5y avg)26.40x25.21x

Forward P/E (FY2026 / FY2027)17.38x16.15x

PEG (TTM / fwd)—2.28

P/S (TTM)1.80x

P/B3.00x

EV/EBITDA (TTM)14.37x

FCF yield (TTM)4.47%

Cash flow & dividend

FCF (TTM)$1.16B

FCF per share (TTM)$14.28

FCF margin (TTM)8.05%

Dividend yield (indicated / 5y avg)0.90%1.17%

Annualized dividend$2.88

Payout ratio (EPS / FCF)23.86%20.70%

Growth & quality

Revenue YoY, latest Q+5.78%

Diluted EPS YoY, latest Q+28.17%

Operating margin (TTM)10.43%

Net margin (TTM)6.99%

ROE (latest FY)10.17%

Net debt / EBITDA (TTM)2.61

Interest coverage (TTM)6.59

Price

+23.00%+4.24%/yrover 5y

Weekly closes · split-adjusted

close 7 Aug 2026

Fundamentals

Fiscal years, last 10, CAGR chips on growth series, plus a dimmed trailing-twelve-month bar

Revenue

5Y CAGR -0.04%10Y CAGR +4.86%

Diluted EPS

5Y CAGR -5.17%10Y CAGR +10.84%

FCF per share

5Y CAGR -1.31%10Y CAGR +8.78%

Operating cash flow

5Y CAGR -5.14%10Y CAGR +5.26%

Free cash flow

5Y CAGR -7.21%10Y CAGR +5.20%

Dividends per share

Payout ratio

FCF payout ratio

Operating margin

FCF margin

Return on equity

Return on capital employed

Shares outstanding

5Y CAGR -6.34%10Y CAGR -3.54%

Net debt / EBITDA

Interest coverage

Earnings

Street estimates, not SEC filings

Next / Q3 FY26

Date26 Oct 2026

EPS estimate$4.74

Revenue estimate$3.86B

Last reported

Date—

EPS——

Revenue——